Strata Skin Sciences Total Non-Operating Income/Expense 2010-2024 | SSKN
Strata Skin Sciences total non-operating income/expense from 2010 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
| Strata Skin Sciences Annual Total Non-Operating Income/Expense (Millions of US $) |
|
|---|---|
| 2023 | $-2 |
| 2022 | $-1 |
| 2021 | $2 |
| 2020 | $-0 |
| 2019 | $-1 |
| 2018 | $-1 |
| 2017 | $-20 |
| 2016 | $1 |
| 2015 | $-8 |
| 2014 | $2 |
| 2013 | $-2 |
| 2012 | $0 |
| 2011 | $0 |
| 2010 | $0 |
| 2009 | $0 |
| Strata Skin Sciences Quarterly Total Non-Operating Income/Expense (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-0 |
| 2024-06-30 | $0 |
| 2024-03-31 | $-0 |
| 2023-12-31 | $-0 |
| 2023-09-30 | $-0 |
| 2023-06-30 | $-1 |
| 2023-03-31 | $-0 |
| 2022-12-31 | $-0 |
| 2022-09-30 | $-0 |
| 2022-06-30 | $-0 |
| 2022-03-31 | $-0 |
| 2021-12-31 | $-0 |
| 2021-09-30 | $-0 |
| 2021-06-30 | $2 |
| 2021-03-31 | $-0 |
| 2020-12-31 | $-0 |
| 2020-09-30 | $-0 |
| 2020-06-30 | $-0 |
| 2020-03-31 | $0 |
| 2019-12-31 | $-0 |
| 2019-09-30 | $-0 |
| 2019-06-30 | $-0 |
| 2019-03-31 | $-0 |
| 2018-12-31 | $0 |
| 2018-09-30 | $-0 |
| 2018-06-30 | $-0 |
| 2018-03-31 | $-0 |
| 2017-12-31 | $-4 |
| 2017-09-30 | $-13 |
| 2017-06-30 | $-1 |
| 2017-03-31 | $-1 |
| 2016-12-31 | $-1 |
| 2016-09-30 | $-1 |
| 2016-06-30 | $2 |
| 2016-03-31 | $1 |
| 2015-12-31 | $1 |
| 2015-09-30 | $-7 |
| 2015-06-30 | $1 |
| 2015-03-31 | $-4 |
| 2014-12-31 | $-1 |
| 2014-09-30 | $2 |
| 2014-06-30 | $5 |
| 2014-03-31 | $-3 |
| 2013-12-31 | $-0 |
| 2013-09-30 | $-1 |
| 2013-06-30 | $-0 |
| 2013-03-31 | $-0 |
| 2012-12-31 | $0 |
| 2012-09-30 | $0 |
| 2012-06-30 | $0 |
| 2012-03-31 | $0 |
| 2011-12-31 | $0 |
| 2011-09-30 | $0 |
| 2011-06-30 | $0 |
| 2011-03-31 | $0 |
| 2010-12-31 | $0 |
| 2010-09-30 | $0 |
| 2010-06-30 | $0 |
| 2010-03-31 | $0 |
| 2009-12-31 | $0 |
| 2009-09-30 | $0 |
| 2009-06-30 | $0 |
| 2009-03-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.012B | $0.033B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.714B | 55.57 |
| Tempus AI (TEM) | United States | $7.994B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $6.961B | 177.00 |
| Inspire Medical Systems (INSP) | United States | $5.693B | 177.56 |
| IRhythm Technologies (IRTC) | United States | $3.453B | 0.00 |
| Privia Health (PRVA) | United States | $2.701B | 225.10 |
| Enovis (ENOV) | United States | $2.693B | 17.94 |
| Azenta (AZTA) | United States | $2.440B | 130.24 |
| Clover Health Investments (CLOV) | United States | $2.230B | 0.00 |
| Omnicell (OMCL) | United States | $2.070B | 67.71 |
| Schrodinger (SDGR) | United States | $1.819B | 0.00 |
| 10x Genomics (TXG) | United States | $1.796B | 0.00 |
| Phreesia (PHR) | United States | $1.669B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.748B | 0.00 |
| Standard BioTools (LAB) | United States | $0.588B | 0.00 |
| Talkspace (TALK) | United States | $0.537B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.515B | 0.00 |
| TruBridge (TBRG) | United States | $0.362B | 105.43 |
| Nyxoah SA (NYXH) | Belgium | $0.354B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.343B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.235B | 0.00 |
| Pulmonx (LUNG) | United States | $0.230B | 0.00 |
| American Well (AMWL) | United States | $0.169B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.096B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.069B | 0.00 |
| CareCloud (CCLD) | United States | $0.058B | 0.00 |
| HeartBeam (BEAT) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.047B | 0.00 |
| Outset Medical (OM) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | China | $0.042B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.035B | 0.00 |
| Movano (MOVE) | United States | $0.034B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.020B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.018B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.005B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |